Figures
Abstract
Emerging evidence has shown that cellular energy metabolism is regulated by the AMPK and MLK3-JNK signaling pathways, but the functional link between them remains to be determined. The present study aimed to explore the crosstalk between MLK3 and AMPK. We found that both JNK and AMPK were phosphorylated at their activation sites by TNF-α, Anisomycin, H2O2 and sorbitol. Interestingly, sorbitol stimulated phosphorylation of AMPK at T172 in LKB1-deficient cells. Following the screening of more than 100 kinases, we identified that MLK3 induced phosphorylation of AMPK at T172. Our in vitro analysis further revealed that MLK3-mediated phosphorylation of AMPK at T172 was independent of AMP, but addition of AMP caused a mobility shift of AMPK, an indication of autophosphorylation, suggesting that AMP binding and phosphorylation of T172 leads to maximal activation of AMPK. GST-pull down assays showed a direct interaction between AMPKα1 subunit and MLK3. Altogether, our results indicate that MLK3 serves as a common upstream kinase of AMPK and JNK and functions as a direct upstream kinase for AMPK independent of LKB1.
Citation: Luo L, Jiang S, Huang D, Lu N, Luo Z (2015) MLK3 Phophorylates AMPK Independently of LKB1. PLoS ONE 10(4): e0123927. https://doi.org/10.1371/journal.pone.0123927
Academic Editor: Mengwei Zang, Boston University School of Medicine, UNITED STATES
Received: December 18, 2014; Accepted: March 9, 2015; Published: April 13, 2015
Copyright: © 2015 Luo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: This study was supported in part by grants from The National Science foundation of China (No.81171952, No.81272926, No.31460304, and No.81460374) and a grant from Jiangxi provincial Department Science and Technology (20133BBG70061).
Competing interests: The authors have declared that no competing interests exist.
Introduction
There are several mitogen-activated-protein kinases (MAPKs) pathways consisting of three tiers of kinases, MAPK, MAPK kinase (MAP2K), and MAPK kinase (MAP3K). When triggered by extracellular and intracellular signals, each is consecutively phosphorylated and activated by its upstream component, leading to an amplification of signaling cascade [1]. MAPK cascades are involved in diverse cellular activities, including mitosis, programmed cell death, motility and metabolism [2]. Substrates for MAPKs include transcription factors, phospholipases, protein kinases, cytoskeleton-associated proteins and membrane receptors.
The mixed-lineage kinases (MLKs) are a family of serine/threonine protein kinases, and the catalytic domain of MLK3 resembles both serine and threonine kinase and tyrosine kinase [3]. MLK belongs to MAP3K that contains four isoforms, MLK1, 2, 3 and 4, all of which encompass an amino-terminal SRC-Homology-3 (SH3) domain, a kinase domain, a leucine-zipper region and a Cdc42/Rac-interactive binding (CRIB) motif [4]. Dimerization is a common mechanism for the activation of MLKs [5]. SH3 domain binds to a proline residue in a region between the leucine zipper and the CRIB motif, which leads to autoinhibition of kinase activity. Disrupting the binging between SH3 and proline residue, for example, deletion of the active leucine zipper [5], binging of GTP-bound Rac or Cdc42 with CRIB [4], results in activation of MLK.
Among MLKs, MLK3 is well studied and plays a crucial role in stress and inflammatory responses through regulation of the JNK pathway by phosphorylating MAP2K4/7 and the p38 MAPK pathway by phosphorylating MAP2K3/6 (Fig 1.) [6]. Depending on the cellular context, MLK3 activation can elicit different cellular responses, even opposing biological responses. In neuronal cells, nerve growth factor (NGF) withdrawal activates MLK3-JNK, which in turn mediates neuronal cell death and pathological neurodegenerative diseases, including Parkinson’s disease (PD). Emerging data suggest that blocking MLKs-JNK signaling can prevent the cell death of neurons. For example, MLKs inhibitor, CEP1347, is now in phase II/III clinical trials for neuroprotection in PD [7]. Moreover, MLK3 promotes the cytokine-induced pancreatic beta cell death in type 1 diabetes [8, 9]. In addition, MLK protein could regulate cell cycle and cell proliferation. Finally, MLKs are expressed in cells of the immune system and involved in toll-like receptor mediated signaling pathway.
In response to extracelluar stimuli, MLK3 is dimerized and activated by Cdc42/Rac [5, 8]. Once activated, MLK3 will activate multipe MAP2Ks, which in turn activate the downstream MAPKs by phosphorylation, such as ERK1/2, JNK, or p38 MAPK. The activated MAPKs will further participate in regulating various cellular processes via transcription factors.
AMPK is a heterotrimeric kinase composed of α catalytic subunit and regulatory β and γ subunits [10], and plays a key role in the regulation of energy homoeostasis [11]. The activation of AMPK is controlled by the allosteric regulators AMP, ADP and ATP, and phosphorylation of T172 by upstream kinases. AMP binds the γ regulatory subunit causing conformational change in holoenzyme while ATP maintains an inactive conformation. Binding of AMP enables phosphorylation by upstream activating kinases leading to maximal activation of AMPK and impedes dephosphorylation by phosphatases [12]. The upstream kinases thus far reported include LKB1, CaMKKβ, and TAK1 [10].
Cellular functions that are mediated by MLK3, such as inflammation, apoptosis, growth, and differentiation are associated with energy metabolism [5]. Recent studies have revealed that MLK3-JNK pathway plays an important role in the mitochondrial dysfunction and apoptosis [13]. Moreover, AMPK, as a sensor of cellular energy status, is associated with activation of JNK as well as apoptosis [14]. These facts suggest a potential functional link between AMPK and MLK3-JNK in the regulation of cellular energy metabolism.
In the present study, we compared the upstream activators for JNK and AMPK and found that they could be activated by similar factors such as Osmotic stress and oxidative stress. Further mechanistic investigation demonstrated that MLK3 activated AMPK in addition to JNK.
Materials and Methods
Materials
Antibodies against p-AMPKα (T172) and pSAPK/JNK were purchased from Cell Signaling Technology (Danvers, MA, USA); Antibodies against AMPKα1, AMPKα2, and LKB1, and recombinant LKB1 protein were purchased from EMD Millipore (Gibbstown, NJ, USA); Antibodies against MLK3 and GST, HRP-conjugated second antibodies and protein A/G agarose were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Myc antibody was from Sigma-Aldrich (St Louise, MO, USA). 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR), Anisomycin, sorbitol, oligomycin, TNFα, IL6 and Adiponectin, glutathione agarose and glutathione were purchased from Sigma-Aldrich (St Louise, MO, USA).
Cell culture, plasmid transfection and establishment of stable cell lines
The lung adenocarcinoma A549 and human embryonic kidney HEK293T cells were purchased from ATCC (Manassas, VA, USA), and also used in other studies [15]. Cells were cultured in DMEM (Gibco, Life Technologies) supplemented with 10% fetal bovine serum in a 5% CO2 and 37°C incubator. The lentivirus carrying LKB1 was packaged in HEK293T cells and supernatant was collected after two days. A549 cells were infected with the supernatant and selected with puromycin [16].
Western blot analysis
Cells were harvested and lysed in lysis buffer (50 mM Tris-HCl [pH 8.0], 50 mM β-glycerophosphate, 1 mM EDTA, 1 mM EGTA, 1 mM NaVO4, 50 mM NaCl, 0.5% Triton x-100, 10 mM NaF, 1 mM DTT, 2 μg/m1 aportinnin, 2 μg/ml leupeptin, 2 μg/ml pepstatin, mM phenylmethylsulfonyl fluoride [PMSF]) on ice for 30 min. Proteins were boiled in 1×SDS loading buffer, separated on SDS-PAGE and transferred onto PVDF membranes (Millipore, Gibbstown, NJ, USA). After blocking in 5% milk for 1 hour, membranes were incubated with primary antibodies at 4 oC overnight. The next day, by incubation with anti-mouse or rabbit IgG secondary antibody, signal was developed with a SuperSignal West Pico Chemiluminescance kit (Thermo-Fisher scientific, Waltham, MA, USA) and exposed to X-ray film.
Glutathione purification
cDNAs GST-AMPKα1 and GST-MLK3 were cloned in pEBG plasmid and transfected into HEK293T cells. Two days after transfection, recombinant proteins were purified with glutatione (GSH) agarose and eluted with reduced GSH (25 mM).
In vitro phosphorylation kinase assay
Recombinant AMPK was mixed with MLK3 or LKB1 in the presence or absence 5 mM AMP, in a buffer containing 50 mM HEPES, 5 mM MgCl2, 1 mM DTT. The kinase assay was initiated by addition of ATP (final concentration of 200 μM) and incubated at 30°C for 30 min. Phosphorylation of AMPK at T172 was determined by western blot analysis.
Results
AMPKα can be phosphorylated by sorbitol independently of LKB1
To find the potential association of AMPK with MLK3-JNK and to search for additional kinases upstream of AMPK independent of LKB1, we chose lung adenocarcinoma A549 cell line lacking LKB1 and established a stable A549 cell line by infection of lentivirus carrying LKB1 cDNA (Fig 2A). The A549 cells (A549-WT) and A549 cells expressing LKB1 (A549-LKB1) were treated with AICAR, IL6, TNF-α, Adiponectin, Anisomycin, H2O2, as well as sorbitol. The phosphorylation of AMPKα and JNK was examined by immunobloting. As shown in Fig 2B, TNF-α, Anisomycin, H2O2, and sorbitol treatment resulted in phosphorylation of SAPK/JNK. All agents stimulated the phosphorylation of AMPKα at T172 in A549-LKB1 cells. Interestingly, sorbitol, which causes osmotic shock, also stimulated the phosphorylation of AMPKα at T172 in A549 cells lacking LKB1 as potently as the cells with LKB1, indicating existence of an additional stress kinase that could phosphorylate and activate AMPK independently on LKB1.
A: A stable A549 cell line was established by infection of lentivirus carrying LKB1 cDNA. LKB1 expression was examined by Western blot. B: A549 cells and stable A549-LKB1 cells were treated with IL6 (10 ng/ml), TNF-α (10 ng/ml), Adiponectin (10 μg/ml), Anisomycin (10 μg/ml), H2O2 (10 mM) and sorbitol (2.5 mM) for 30 min, or AICAR (1mM) for 2 h. Total proteins were extracted and blotted with antibodies as indicated.
MLK3 phosphorylates AMPK in the absence of AMP
To search additional kinases that might phosphorylate AMPKα independently of LKB1, we transfected HEK293T cells individually with plasmids of LKB1, TAK1, IKKβ, MLK3, and additional 100 kinases, and determined pAMPKα-T172 status by immunoblotting. Our data showed that besides LKB1, ectopic overexpression of MLK3 led to potent phosphorylation of AMPKα, which was even greater than LKB1 (Fig 3A), indicating that AMPKα can be phosphorylated by MLK3. Interestingly, we could not observe T172 phosphorylation by TAK1 (data not shown).
A: HEK293 cells were transfected with empty control, MLK3 or LKB1 vectors. Total proteins were extracted for immunoblotting of pAMPKα-T172 and AMPKα. B: Recombinant AMPK and MLK3 were respectively expressed in HEK293T cells and purified by GSH. In vitro kinase assays were performed as indicated in the presence or absence of AMP. The phosphorylation of AMPK at T172 was determined by western blot analysis.
We next performed an in vitro kinase assay in which purified kinases were added together in the presence or absence of AMP. To do this, we first expressed MLK3 and AMPK as GST fusion proteins separately, purified the recombinant proteins with GHS agarose beads and eluted them with reduced GSH. GST-LKB1 was used as a positive control. As shown in Fig 3B, phosphorylation of AMPKα1 by LKB1 was increased by addition of AMP. In contrast, MLK3 potently phosphorylated pAMPK-T172 without AMP, but addition of AMP caused an apparently shift in mobility although it did not change the level of pAMPK-T172. These results demonstrated that MLK3 phosphorylate AMPK in the absence of AMP but maximal activation could be achieved by binding of AMP, as suggested by autophosphorylation (a mobility shift).
MLK3 physically interacts with AMPKα1
To assess if MLK3 directly associates with AMPK, we transfected HEK293 cells with GST-MLK3 or GST-LKB1 (in pEBG), pulled down MLK3 or LKB1 protein with GSH beads, and examined the association of GST-MLK3 or LKB1 with endogenous AMPKα1 or AMPKα2. MLK3 appeared to bind to α1 subunit strongly, as compared with LKB1 (Fig 4A). To further validate the binding of MLK3 to α1, we co-transfected pEBG-MLK3 with Myc-AMPKα1 or α2 in HEK293 cells, purified MLK3 by GSH beads, and then blotted with antibody against Myc epitope. As shown in Fig 4B, MLK3 preferentially associated with Myc-AMPKα1, but not Myc-AMPKα2. This association was not due to Myc-AMPKα1 binding to GST.
A: HEK293T cells were transfected with GST-MLK3 or GST-LKB1, and then MLK3 and LKB1 were pulled down with GSH beads and blotted with anti-GST antibody. B: HEK293T cells were transfected with GST empty vector, GST-MLK3 or GST-LKB1, and then recombinant proteins were pulled down with GSH beads and blotted with anti-AMPKα, anti-AMPKα1, as well as anti-AMPKα2. C: GST-MLK3 or GST was co-expressed either with Myc-AMPKα1 or Myc-AMPKα2 in HEK293T cells. Immunoblotting was performed on GSH-pulldown and crude extracts with antibodies against GST and Myc, respectively.
Discussion
Under different stresses, we found JNK and AMPK were often phosphorylated by similar factors. TNF-α, Anisomycin, H2O2 and sorbitol were able to activate both AMPK and JNK (Fig 2), suggesting there might be a crosstalk between AMPK and MLK3-JNK pathways. Particularly, sorbitol was able to activate the phosphorylation of AMPK in LKB1-deficient cells, demonstrating that sorbitol activates AMPK in an LKB1-independent way. To explore additional stress kinases that might act upstream of AMPK by directly phosphorylating AMPK at T172, we screened more than 100 kinases and identified two kinases, MLK3 and IKKβ (data not shown), which could induce AMPK phosphorylation. Our in vitro and in vivo analyses further revealed that expression of MLK3 induced phosphorylation of AMPK at T172 in the absence of AMP (Fig 3). Our GST-pull down assays showed a direct interaction between AMPKα1 subunit and MLK3. These results indicated that MLK3 served as a common upstream kinase of AMPK and JNK, and functioned as a direct upstream kinase for AMPK independent of LKB1 (Fig 5.). Comparing the two upstream kinase of AMPK, we found there was indeed some difference between MLK3 and LKB1 in activating AMPK. It is well known that binding of AMP enables phosphorylaiton of AMPK at T172 by LKB1. However, we found that MLK3 phosphorylated AMPK without AMP, but the latter seemed to cooperate with phosphorylation, leading to maximal activation of AMPK. Metformin, a classical AMPK activator, inhibits Complex I of the respiratory chain, and hence activates AMPK by increase the ratio of AMP to ATP; 2-Deoxyglucose is well known for its function in activating AMPK in part by depleting ATP due to its rapid and uncontrolled phosphorylation by hexokinase [10]; AICAR activates AMPK through intracellular conversion to ZMP, an analog of AMP [17]; IL6 can activate AMPK by increasing the concentrations of AMP [17, 18]. Activation of AMPK by the above four drugs depends on LKB1. In agreement, our results demonstrated that the activation of AMPK by LKB1 requires AMP. In all stimuli tested in this study, we only found that sorbitol activated AMPK in the absence of LKB1; whether sorbitol activates AMPK via MLK3 remains to be determined.
In summary, we found that sorbitol activated JNK as well as AMPK independently of LKB1. Most importantly, we discovered that MLK3 phosphorylated AMPK both in vitro and in vivo and physically associated with AMPKα1. Our study suggests that MLK3 is an upstream kinase that directly phosphorylates AMPK. The AMPK and JNK signaling pathways are both associated with cell proliferation and tumorigenesis. The discovery of MLK3 as a common upstream kinase of AMPK and JNK suggest that activation of MLK3 may not only activate AMPK to inhibit cell metabolism via mTORC1 signaling but also stimulate JNK signal to promote cell apoptosis [19]. Our findings suggest that MLK3 may serve as an anti-cancer drug target.
Acknowledgments
This study was supported in part by grants from The National Science foundation of China (No.81171952, No.81272926, No.31460304, and No.81460374) and a grant from Jiangxi provincial Department Science and Technology (20133BBG70061). We thank Drs. Kunhe Zhang and Yong Xie for providing technical supports.
Author Contributions
Conceived and designed the experiments: LYL. Performed the experiments: SSJ. Analyzed the data: DQH. Contributed reagents/materials/analysis tools: NHL. Wrote the paper: ZJL. Experimental design, interpret data, and write manuscript: ZJL.
References
- 1. Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92(2): 689–737. pmid:22535895
- 2. Koul HK, Pal M, Koul S (2013) Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer 4(9–10): 342–359. pmid:24386511
- 3. Handley ME, Rasaiyaah J, Chain BM, Katz DR (2007) Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity? International Journal of Experimental Pathology 88(2): 111–126. pmid:17408454
- 4. Du Y (2005) Cdc42 Induces Activation Loop Phosphorylation and Membrane Targeting of Mixed Lineage Kinase 3. Journal of Biological Chemistry 280(52): 42984–42993. pmid:16253996
- 5. Gallo KA, Johnson GL (2002) Signalling: Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 3(9):663–72. pmid:12209126
- 6. Rana A, Rana B, Mishra R, Sondarva G, Rangasamy V, Das S, et al. (2013) Mixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer. Genes Cancer 4(9–10): 334–341. pmid:24386511
- 7. Birch-Machin MA (2006) The role of mitochondria in ageing and carcinogenesis. Clin Exp Dermatol 31(4): 548–552. pmid:16716161
- 8. Chadee DN (2013) Involvement of mixed lineage kinase 3 in cancer1. Canadian Journal of Physiology and Pharmacology 91(4): 268–274. pmid:23627838
- 9. Maki CG, Lin C-J, Lee C-C, Shih Y-L, Lin C-H, Wang S-H, et al. (2012) Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells. PLoS One 7(6): e38706. pmid:22745676
- 10. Hardie DG, Ross FA, Hawley SA (2012) AMP-activated protein kinase: a target for drugs both ancient and modern. Chem Biol 19(10): 1222–1236. pmid:23102217
- 11. Russo GL, Russo M, Ungaro P (2013) AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem Pharmacol 86(3): 339–350. pmid:23747347
- 12. Luo Z, Zang M, Guo W (2010) AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6(3): 457–470. pmid:20222801
- 13. Rangasamy V, Mishra R, Sondarva G, Das S, Lee TH, Bakowska JC, et al. (2012) Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function. Proceedings of the National Academy of Sciences 109(21): 8149–8154. pmid:22566623
- 14. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D, et al. (2003) AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 30(2): 151–161. pmid:12683939
- 15. Luo L, Huang W, Tao R, Hu N, Xiao ZX, Luo Z (2013) ATM and LKB1 dependent activation of AMPK sensitizes cancer cells to etoposide-induced apoptosis.Cancer Lett. 328(1):114–9. pmid:22960274
- 16. Zhou J, Huang W, Tao R, Ibaragi S, Lan F, Ido Y, et al. (2009) Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells. Oncogene 28(18): 1993–2002. pmid:19347029
- 17. Kelly M, Gauthier MS, Saha AK, Ruderman NB (2009) Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes 58(9): 1953–1960. pmid:19502419
- 18. Sarvas JL, Khaper N, Lees SJ (2013) The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J Diabetes Metab Suppl 13 pmid:24244888
- 19. Hamdi M, Kool J, Cornelissen-Steijger P, Carlotti F, Popeijus HE, van der Burgt C, et al. (2005) DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1. Oncogene 24(48): 7135–7144. pmid:16044158